Medirom Historical Financial Ratios

MRM Stock

USD 0.93 0.01 1.06%

Medirom Healthcare is lately reporting on over 93 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as Days Sales Outstanding of 21.35 will help investors to properly organize and evaluate Medirom Healthcare financial condition quickly.

Quick Ratio Current Ratio

Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Medirom Healthcare Technologies. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

About Medirom Financial Ratios Analysis

Medirom HealthcareFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate Medirom Healthcare investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on Medirom financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across Medirom Healthcare history.

Medirom Healthcare Financial Ratios Chart

At this time, Medirom Healthcare's Days Of Inventory On Hand is very stable compared to the past year. As of the 24th of January 2025, Days Payables Outstanding is likely to grow to 16.50, while Book Value Per Share is likely to drop 41.43.

Price To Sales Ratio Days Sales Outstanding Capex To Depreciation Ev To Sales Inventory Turnover Net Current Asset Value

Add Fundamental

Price To Sales Ratio

Price to Sales Ratio is figured by comparing Medirom Healthcare stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Medirom Healthcare sales, a figure that is much harder to manipulate than other Medirom Healthcare Technologies multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.

Capex To Depreciation

The ratio of a company's capital expenditures to its depreciation expenses, indicating how much the company is investing in physical assets relative to the aging of existing assets.

Ev To Sales

The Enterprise Value to Sales ratio, a valuation metric used to compare the value of a company, including debt and excluding cash, to its sales revenue.

Inventory Turnover

A ratio showing how many times a company's inventory is sold and replaced over a period, indicating the efficiency of inventory management.

Most ratios from Medirom Healthcare's fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into Medirom Healthcare current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Medirom Healthcare Technologies. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

	2022	2023	2024	2025 (projected)
Payables Turnover	24.34	38.19	34.37	21.99
Days Of Inventory On Hand	8.24	9.72	8.74	9.18

Payables Turnover Days Of Inventory On Hand

Medirom Healthcare fundamentals Correlations

	Price To Sales Ratio	Ptb Ratio	Days Sales Outstanding	Book Value Per Share	Free Cash Flow Yield	Operating Cash Flow Per Share	Capex To Depreciation	Pb Ratio	Ev To Sales	Free Cash Flow Per Share	Roic	Inventory Turnover	Net Income Per Share	Days Of Inventory On Hand	Payables Turnover	Capex To Revenue	Cash Per Share	Pocfratio	Interest Coverage	Capex To Operating Cash Flow	Pfcf Ratio	Days Payables Outstanding	Income Quality	Roe	Ev To Operating Cash Flow	Pe Ratio
Price To Sales Ratio		-0.66	0.24	-0.26	0.95	0.91	0.27	-0.66	0.99	0.91	0.7	0.84	0.28	-0.8	-0.53	-0.68	-0.01	0.14	0.47	0.65	0.03	0.62	0.83	-0.38	0.16	0.45
Ptb Ratio	-0.66		-0.4	0.8	-0.66	-0.79	-0.27	1.0	-0.69	-0.78	-0.83	-0.51	-0.3	0.6	0.77	0.44	0.29	0.21	-0.69	-0.37	0.32	-0.82	-0.72	0.38	0.2	-0.12
Days Sales Outstanding	0.24	-0.4		-0.29	0.38	0.5	-0.58	-0.4	0.34	0.49	0.33	0.19	0.75	-0.04	-0.33	-0.51	-0.66	0.27	0.83	0.51	0.19	0.28	0.13	-0.29	0.27	0.52
Book Value Per Share	-0.26	0.8	-0.29		-0.23	-0.4	-0.28	0.8	-0.34	-0.39	-0.38	-0.04	-0.13	0.23	0.74	0.12	0.59	0.55	-0.47	0.07	0.63	-0.79	-0.38	-0.08	0.54	0.28
Free Cash Flow Yield	0.95	-0.66	0.38	-0.23		0.97	0.12	-0.66	0.94	0.97	0.78	0.93	0.23	-0.87	-0.5	-0.69	0.0	0.29	0.49	0.77	0.17	0.59	0.9	-0.31	0.3	0.57
Operating Cash Flow Per Share	0.91	-0.79	0.5	-0.4	0.97		0.05	-0.79	0.93	1.0	0.85	0.88	0.32	-0.83	-0.65	-0.74	-0.16	0.25	0.65	0.78	0.12	0.72	0.89	-0.33	0.26	0.57
Capex To Depreciation	0.27	-0.27	-0.58	-0.28	0.12	0.05		-0.27	0.24	0.03	0.07	0.04	-0.37	-0.24	0.07	0.46	0.42	-0.75	-0.4	-0.48	-0.75	0.08	0.29	-0.13	-0.74	-0.68
Pb Ratio	-0.66	1.0	-0.4	0.8	-0.66	-0.79	-0.27		-0.69	-0.78	-0.83	-0.51	-0.3	0.6	0.77	0.44	0.29	0.21	-0.69	-0.37	0.32	-0.82	-0.72	0.38	0.2	-0.12
Ev To Sales	0.99	-0.69	0.34	-0.34	0.94	0.93	0.24	-0.69		0.92	0.67	0.79	0.37	-0.74	-0.56	-0.68	-0.15	0.09	0.53	0.63	-0.03	0.65	0.8	-0.36	0.1	0.43
Free Cash Flow Per Share	0.91	-0.78	0.49	-0.39	0.97	1.0	0.03	-0.78	0.92		0.86	0.89	0.3	-0.85	-0.65	-0.75	-0.14	0.27	0.65	0.79	0.14	0.72	0.9	-0.32	0.28	0.58
Roic	0.7	-0.83	0.33	-0.38	0.78	0.85	0.07	-0.83	0.67	0.86		0.79	0.18	-0.78	-0.61	-0.6	0.09	0.26	0.61	0.69	0.15	0.65	0.83	-0.47	0.27	0.47
Inventory Turnover	0.84	-0.51	0.19	-0.04	0.93	0.88	0.04	-0.51	0.79	0.89	0.79		-0.02	-0.95	-0.44	-0.69	0.23	0.49	0.32	0.84	0.4	0.52	0.92	-0.19	0.5	0.66
Net Income Per Share	0.28	-0.3	0.75	-0.13	0.23	0.32	-0.37	-0.3	0.37	0.3	0.18	-0.02		0.23	-0.21	-0.47	-0.56	0.11	0.81	0.3	0.05	0.12	-0.14	-0.65	0.11	0.36
Days Of Inventory On Hand	-0.8	0.6	-0.04	0.23	-0.87	-0.83	-0.24	0.6	-0.74	-0.85	-0.78	-0.95	0.23		0.51	0.53	-0.24	-0.27	-0.19	-0.67	-0.18	-0.62	-0.98	0.04	-0.29	-0.44
Payables Turnover	-0.53	0.77	-0.33	0.74	-0.5	-0.65	0.07	0.77	-0.56	-0.65	-0.61	-0.44	-0.21	0.51		0.7	0.56	-0.06	-0.66	-0.49	0.04	-0.98	-0.58	-0.07	-0.07	-0.32
Capex To Revenue	-0.68	0.44	-0.51	0.12	-0.69	-0.74	0.46	0.44	-0.68	-0.75	-0.6	-0.69	-0.47	0.53	0.7		0.36	-0.65	-0.72	-0.91	-0.55	-0.63	-0.53	0.18	-0.66	-0.87
Cash Per Share	-0.01	0.29	-0.66	0.59	0.0	-0.16	0.42	0.29	-0.15	-0.14	0.09	0.23	-0.56	-0.24	0.56	0.36		0.12	-0.62	-0.08	0.17	-0.48	0.13	-0.19	0.12	-0.11
Pocfratio	0.14	0.21	0.27	0.55	0.29	0.25	-0.75	0.21	0.09	0.27	0.26	0.49	0.11	-0.27	-0.06	-0.65	0.12		0.23	0.8	0.99	-0.04	0.16	-0.01	1.0	0.92
Interest Coverage	0.47	-0.69	0.83	-0.47	0.49	0.65	-0.4	-0.69	0.53	0.65	0.61	0.32	0.81	-0.19	-0.66	-0.72	-0.62	0.23		0.59	0.13	0.59	0.3	-0.5	0.24	0.54
Capex To Operating Cash Flow	0.65	-0.37	0.51	0.07	0.77	0.78	-0.48	-0.37	0.63	0.79	0.69	0.84	0.3	-0.67	-0.49	-0.91	-0.08	0.8	0.59		0.71	0.46	0.64	-0.21	0.81	0.95
Pfcf Ratio	0.03	0.32	0.19	0.63	0.17	0.12	-0.75	0.32	-0.03	0.14	0.15	0.4	0.05	-0.18	0.04	-0.55	0.17	0.99	0.13	0.71		-0.15	0.05	0.03	0.99	0.86
Days Payables Outstanding	0.62	-0.82	0.28	-0.79	0.59	0.72	0.08	-0.82	0.65	0.72	0.65	0.52	0.12	-0.62	-0.98	-0.63	-0.48	-0.04	0.59	0.46	-0.15		0.7	0.09	-0.03	0.25
Income Quality	0.83	-0.72	0.13	-0.38	0.9	0.89	0.29	-0.72	0.8	0.9	0.83	0.92	-0.14	-0.98	-0.58	-0.53	0.13	0.16	0.3	0.64	0.05	0.7		-0.09	0.17	0.37
Roe	-0.38	0.38	-0.29	-0.08	-0.31	-0.33	-0.13	0.38	-0.36	-0.32	-0.47	-0.19	-0.65	0.04	-0.07	0.18	-0.19	-0.01	-0.5	-0.21	0.03	0.09	-0.09		-0.02	-0.17
Ev To Operating Cash Flow	0.16	0.2	0.27	0.54	0.3	0.26	-0.74	0.2	0.1	0.28	0.27	0.5	0.11	-0.29	-0.07	-0.66	0.12	1.0	0.24	0.81	0.99	-0.03	0.17	-0.02		0.92
Pe Ratio	0.45	-0.12	0.52	0.28	0.57	0.57	-0.68	-0.12	0.43	0.58	0.47	0.66	0.36	-0.44	-0.32	-0.87	-0.11	0.92	0.54	0.95	0.86	0.25	0.37	-0.17	0.92

Click cells to compare fundamentals

Medirom Healthcare Account Relationship Matchups

Medirom Healthcare fundamentals Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Ptb Ratio	12.18	(16.31)	(54.48)	19.75	17.78	18.66
Days Sales Outstanding	16.22	21.07	28.06	33.24	29.92	21.35
Book Value Per Share	122.06	(42.72)	(10.85)	41.81	48.08	41.43
Free Cash Flow Yield	(0.0735)	(0.19)	(0.25)	(0.18)	(0.21)	(0.22)
Operating Cash Flow Per Share	(91.05)	(114.25)	(125.34)	(122.29)	(140.64)	(147.67)
Capex To Depreciation	1.18	0.76	0.66	0.54	0.62	0.75
Pb Ratio	12.18	(16.31)	(54.48)	19.75	17.78	18.66
Ev To Sales	1.93	0.94	0.73	1.13	1.3	1.77
Free Cash Flow Per Share	(109.32)	(133.86)	(147.41)	(148.59)	(170.88)	(179.42)
Roic	(0.18)	(0.27)	0.0202	(0.48)	(0.55)	(0.52)
Inventory Turnover	366.1	213.57	44.27	37.57	43.21	41.04
Net Income Per Share	(133.97)	(203.13)	27.23	22.27	20.04	21.05
Days Of Inventory On Hand	1.0	1.71	8.24	9.72	8.74	9.18
Payables Turnover	43.46	17.3	24.34	38.19	34.37	21.99
Capex To Revenue	0.022	0.0177	0.0174	0.0199	0.0179	0.0118
Cash Per Share	365.82	77.32	110.77	20.68	23.79	22.6
Pocfratio	(16.33)	(6.1)	(4.72)	(6.59)	(7.58)	(7.2)
Interest Coverage	(48.33)	(33.09)	9.89	(10.62)	(12.21)	(12.82)
Capex To Operating Cash Flow	(0.2)	(0.17)	(0.18)	(0.22)	(0.25)	(0.23)
Pfcf Ratio	(13.6)	(5.2)	(4.01)	(5.43)	(6.24)	(5.93)
Days Payables Outstanding	8.4	21.1	15.0	9.56	10.99	16.5
Income Quality	0.68	0.56	(4.6)	(5.49)	(6.31)	(6.0)
Roe	(1.1)	4.76	(2.51)	0.55	0.49	0.52
Ev To Operating Cash Flow	(17.6)	(9.09)	(7.42)	(12.2)	(14.03)	(13.33)
Pe Ratio	(11.1)	(3.43)	21.71	36.2	41.63	39.55
Return On Tangible Assets	(0.0987)	(0.21)	0.0257	0.0211	0.0243	0.0255
Ev To Free Cash Flow	(14.65)	(7.76)	(6.31)	(10.04)	(11.55)	(10.97)
Earnings Yield	(0.0901)	(0.29)	0.0461	0.0276	0.0249	0.0261
Intangibles To Total Assets	0.0435	0.17	0.14	0.21	0.18	0.19
Net Debt To E B I T D A	(0.8)	(6.19)	6.6	11.43	13.14	13.8
Current Ratio	0.79	0.43	0.65	0.49	0.44	0.45
Tangible Book Value Per Share	60.36	(245.98)	(183.26)	(230.23)	(264.76)	(251.52)
Receivables Turnover	22.5	17.32	13.01	10.98	12.63	16.05
Graham Number	606.58	441.85	81.55	143.02	128.72	196.66
Shareholders Equity Per Share	122.06	(42.72)	(10.85)	40.82	46.95	41.24
Debt To Equity	3.87	(9.78)	(41.46)	17.31	15.57	16.35
Capex Per Share	18.28	19.61	22.07	26.3	23.67	12.7
Graham Net Net	(903.1)	(1.1K)	(1.0K)	(1.2K)	(1.3K)	(1.4K)
Revenue Per Share	830.31	1.1K	1.3K	1.3K	1.2K	823.29

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

When determining whether Medirom Healthcare is a strong investment it is important to analyze Medirom Healthcare's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Medirom Healthcare's future performance. For an informed investment choice regarding Medirom Stock, refer to the following important reports:

How To Invest In Medirom

Details

Is Medirom Stock a good investment?

Details

What is Medirom Healthcare's Net Worth?

Details

Largest Health Care Providers & Services Companies

View

Largest Health Care Equipment & Services Companies

View

You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.

Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Medirom Healthcare. If investors know Medirom will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Medirom Healthcare listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

0.582

Earnings Share

(0.15)

Revenue Per Share

1.4 K

Quarterly Revenue Growth

(0.06)

Return On Assets

(0.04)

The market value of Medirom Healthcare is measured differently than its book value, which is the value of Medirom that is recorded on the company's balance sheet. Investors also form their own opinion of Medirom Healthcare's value that differs from its market value or its book value, called intrinsic value, which is Medirom Healthcare's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Medirom Healthcare's market value can be influenced by many factors that don't directly affect Medirom Healthcare's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Medirom Healthcare's value and its price as these two are different measures arrived at by different means. Investors typically determine if Medirom Healthcare is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Medirom Healthcare's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Price To Sales Ratio	Dividend Yield
Ptb Ratio	Days Sales Outstanding
Book Value Per Share	Free Cash Flow Yield
Invested Capital	Operating Cash Flow Per Share
Average Payables	Stock Based Compensation To Revenue
Capex To Depreciation	Pb Ratio
Ev To Sales	Free Cash Flow Per Share
Roic	Inventory Turnover
Net Income Per Share	Days Of Inventory On Hand
Payables Turnover	Sales General And Administrative To Revenue
Average Inventory	Research And Ddevelopement To Revenue
Capex To Revenue	Cash Per Share
Pocfratio	Interest Coverage
Payout Ratio	Capex To Operating Cash Flow
Pfcf Ratio	Days Payables Outstanding
Net Current Asset Value	Income Quality
Roe	Tangible Asset Value
Ev To Operating Cash Flow	Pe Ratio
Return On Tangible Assets	Ev To Free Cash Flow
Earnings Yield	Intangibles To Total Assets
Net Debt To E B I T D A	Current Ratio
Tangible Book Value Per Share	Receivables Turnover
Graham Number	Shareholders Equity Per Share
Debt To Equity	Capex Per Share
Graham Net Net	Average Receivables
Revenue Per Share	Interest Debt Per Share
Debt To Assets	Enterprise Value Over E B I T D A
Short Term Coverage Ratios	Price Earnings Ratio
Operating Cycle	Price Book Value Ratio
Price Earnings To Growth Ratio	Days Of Payables Outstanding
Dividend Payout Ratio	Price To Operating Cash Flows Ratio
Price To Free Cash Flows Ratio	Pretax Profit Margin
Ebt Per Ebit	Operating Profit Margin
Effective Tax Rate	Company Equity Multiplier
Long Term Debt To Capitalization	Total Debt To Capitalization
Return On Capital Employed	Debt Equity Ratio
Ebit Per Revenue	Quick Ratio
Dividend Paid And Capex Coverage Ratio	Net Income Per E B T
Cash Ratio	Cash Conversion Cycle
Operating Cash Flow Sales Ratio	Days Of Inventory Outstanding
Days Of Sales Outstanding	Free Cash Flow Operating Cash Flow Ratio
Cash Flow Coverage Ratios	Price To Book Ratio
Fixed Asset Turnover	Capital Expenditure Coverage Ratio
Price Cash Flow Ratio	Enterprise Value Multiple
Debt Ratio	Cash Flow To Debt Ratio
Price Sales Ratio	Return On Assets
Asset Turnover	Net Profit Margin
Gross Profit Margin	Price Fair Value
Return On Equity

Medirom Historical Financial Ratios

About Medirom Financial Ratios Analysis

Medirom Healthcare Financial Ratios Chart

Price To Sales Ratio

Capex To Depreciation

Ev To Sales

Inventory Turnover

Medirom Healthcare fundamentals Correlations

Medirom Healthcare Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Medirom Healthcare fundamentals Accounts

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Pb Ratio	+ 1.0	Ptb Ratio
Free Cash Flow Per Share	+ 1.0	Operating Cash Flow Per Share
Ev To Operating Cash Flow	+ 1.0	Pocfratio
Ev To Sales	+ 0.99	Price To Sales Ratio
Pfcf Ratio	+ 0.99	Pocfratio
Ev To Operating Cash Flow	+ 0.99	Pfcf Ratio

Days Payables Outstanding	- 0.98	Payables Turnover
Income Quality	- 0.98	Days Of Inventory On Hand
Days Of Inventory On Hand	- 0.95	Inventory Turnover
Capex To Operating Cash Flow	- 0.91	Capex To Revenue
Pe Ratio	- 0.87	Capex To Revenue
Days Of Inventory On Hand	- 0.87	Free Cash Flow Yield